KPP Advisory Services’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$400K Buy
24,591
+1,354
+6% +$22.6K 0.06% 243
2025
Q4
$390K Hold
23,237
0.06% 232
2025
Q3
$360K Sell
23,237
-318
-1% -$4.35K 0.05% 248
2025
Q2
$302K Buy
23,555
+1,681
+8% +$20.7K 0.05% 254
2025
Q1
$278K Buy
21,874
+362
+2% +$4.9K 0.05% 251
2024
Q4
$282K Sell
21,512
-455
-2% -$6.56K 0.07% 206
2024
Q3
$331K Sell
21,967
-1,502
-6% -$22.7K 0.08% 185
2024
Q2
$333K Sell
23,469
-463
-2% -$6.26K 0.09% 173
2024
Q1
$326K Buy
+23,932
New +$331K 0.09% 176
2023
Q4
Sell
-22,028
Closed -$275K 159
2023
Q3
$275K Buy
+22,028
New +$290K 0.09% 163

Other funds holding HQL

KPP Advisory Services's HQL Position: Q1 2026 in Review

KPP Advisory Services increased its abrdn Life Sciences Investors (HQL) stake by 5.8% in Q1 2026, buying an estimated $22.6K and bringing the position to 24,591 shares worth $400K. The position accounts for 0.06% of the portfolio, ranked #243.

KPP Advisory Services first reported a position in HQL in Q3 2023 and has held it in 10 quarters since. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • KPP Advisory Services held 24,591 shares of abrdn Life Sciences Investors worth $400K as of Q1 2026.
  • KPP Advisory Services bought 1,354 abrdn Life Sciences Investors shares in Q1 2026, an estimated $22.6K.
  • abrdn Life Sciences Investors made up 0.06% of KPP Advisory Services's portfolio in Q1 2026, its #243 holding.
  • KPP Advisory Services first reported a position in abrdn Life Sciences Investors in Q3 2023 and has held it in 10 quarters since.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on KPP Advisory Services's 13F filing for Q1 2026, filed 24 Apr 2026.